Safety first!

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 10 (PDF).
This issue includes drug safety advice articles on rimonabant (Acomplia): depression; psychiatric adverse reactions and exenatide (Byetta): risk of acute pancreatitis.

Hat tip: http://www.prescriber.org.uk/